Position in CGEN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,381
+$3,778 QoQ
Shares Held
4,851
+56.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 82 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. CGEN ranks #317 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in CGEN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,381 | 4,851 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $6,603 | 3,100 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $4,743 | 3,100 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $8,673 | 5,900 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $10,502 | 5,900 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $25,404 | 17,400 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $29,682 | 19,400 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $42,354 | 23,400 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $77,112 | 45,900 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $110,682 | 42,900 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $12,276 | 6,200 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $5,208 | 5,600 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,384 | 5,600 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $3,920 | 5,600 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $4,752 | 6,600 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,026 | 6,100 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $14,985 | 8,100 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $26,082 | 8,100 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $34,830 | 8,100 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $53,938 | 9,035 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $83,089 | 10,035 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $160,262 | 18,657 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $93,924 | 7,756 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $75,220 | 4,629 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $598,096 | 39,820 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $217,328 | 29,935 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||